267 related articles for article (PubMed ID: 25497847)
1. Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study.
Cai G; Zhu J; Hu W; Zhang Z
Radiat Oncol; 2014 Dec; 9():278. PubMed ID: 25497847
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.
Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z
Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149
[TBL] [Abstract][Full Text] [Related]
4. Once-daily reirradiation for rectal cancer in patients who have received previous pelvic radiotherapy.
Ng MK; Leong T; Heriot AG; Ngan SY
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):512-8. PubMed ID: 23870353
[TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation.
Das P; Delclos ME; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Eng C; Bedi M; Krishnan S; Crane CH
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):60-5. PubMed ID: 19695792
[TBL] [Abstract][Full Text] [Related]
6. The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer.
Susko M; Lee J; Salama J; Thomas S; Uronis H; Hsu D; Migaly J; Willett C; Czito B; Palta M
Ann Surg Oncol; 2016 Oct; 23(11):3609-3615. PubMed ID: 27169769
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity.
Tao R; Tsai CJ; Jensen G; Eng C; Kopetz S; Overman MJ; Skibber JM; Rodriguez-Bigas M; Chang GJ; You YN; Bednarski BK; Minsky BD; Delclos ME; Koay E; Krishnan S; Crane CH; Das P
Radiother Oncol; 2017 Jan; 122(1):146-151. PubMed ID: 28057329
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma.
Glynne-Jones R; Saunders MI; Hoskin P; Phillips H
Clin Oncol (R Coll Radiol); 1999; 11(5):334-9. PubMed ID: 10591822
[TBL] [Abstract][Full Text] [Related]
10. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.
Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731
[TBL] [Abstract][Full Text] [Related]
11. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
[TBL] [Abstract][Full Text] [Related]
12. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer.
Coucke PA; Sartorelli B; Cuttat JF; Jeanneret W; Gillet M; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):181-8. PubMed ID: 7721615
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation to the pelvis for recurrent rectal cancer.
Koom WS; Choi Y; Shim SJ; Cha J; Seong J; Kim NK; Nam KC; Keum KC
J Surg Oncol; 2012 Jun; 105(7):637-42. PubMed ID: 22213210
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
[TBL] [Abstract][Full Text] [Related]
16. Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R; Liu YP; Xie YL; Lin C; Duan CY; Chen DP; Pan Y; Qi B; Zou X; Guo L; Cao JY; Zhang YN; Wang ZQ; Liu YL; Ouyang YF; Wen K; Yang Q; Xie RQ; Li HF; Duan XT; Ding X; Peng L; Chen SY; Liang JL; Feng ZK; Xia TL; Xie RL; Jiang R; Gu CM; Liu RZ; Sun R; Yang X; Liu LZ; Ling L; Liu Q; Ng WT; Hua YJ; Huang PY; Chen MY
Lancet; 2023 Mar; 401(10380):917-927. PubMed ID: 36842439
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation Using Carbon Ions in Patients with Locally Recurrent Rectal Cancer at HIT: First Results.
Habermehl D; Wagner M; Ellerbrock M; Büchler MW; Jäkel O; Debus J; Combs SE
Ann Surg Oncol; 2015; 22(6):2068-74. PubMed ID: 25384705
[TBL] [Abstract][Full Text] [Related]
18. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
[TBL] [Abstract][Full Text] [Related]
19. Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?
Xu B; Guo Y; Chen Y; Lu H; Tang T; Yue Z; Guan G; Chi P; Lin C
Radiat Oncol; 2015 Dec; 10():257. PubMed ID: 26684643
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
Rochet N; Sterzing F; Jensen AD; Dinkel J; Herfarth KK; Schubert K; Eichbaum MH; Schneeweiss A; Sohn C; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1382-9. PubMed ID: 19628341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
